Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;43(9):2740-2754.
doi: 10.1002/hed.26738. Epub 2021 May 14.

The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma

Chien-An Ko  1 , Ku-Hao Fang  2 , Cheng-Ming Hsu  1 , Yi-Chan Lee  3 , Geng-He Chang  1 , Ethan I Huang  1 , Ming-Shao Tsai  1 , Yao-Te Tsai  1
Affiliations

The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma

Chien-An Ko et al. Head Neck. 2021 Sep.

Abstract

Background: We aimed to investigate the preoperative C-reactive protein (CRP)-lymphocyte ratio (CLR) as a prognostic biomarker in oral cavity squamous cell carcinoma (OSCC).

Methods: Three hundred and sixteen patients with OSCC treated with curative surgery were retrospectively assessed and the receiver operating characteristic curve was used to evaluate the discriminative ability of inflammatory markers. The prognostic value of CLR was investigated with Cox proportional hazards analysis.

Results: The CLR cutoff of 3.88 (p < 0.001) demonstrated optimal prognostic performance compared with other inflammatory combinations. A higher preoperative CLR (≥3.88) was significantly associated with clinicopathological aggressiveness and predicted unfavorable overall survival and disease-free survival (hazard ratios = 3.498 and 1.994, respectively; both p < 0.001). The CLR-based nomogram provided accurate survival prediction (concordance index: 0.803).

Conclusions: Preoperative CLR is a feasible prognostic biomarker in patients with OSCC, and the CLR-based nomogram might serve as prognostic tool in era of personalized medicine.

Keywords: C-reactive protein-lymphocyte ratio; biomarker; nomogram; oral cavity cancer; prognosis.

PubMed Disclaimer

References

REFERENCES

    1. Ettinger KS, Ganry L, Fernandes RP. Oral cavity cancer. Oral Maxillofac Surg Clin North Am. 2019;31:13-29.
    1. Acharya S, Kale J, Hallikeri K, Anehosur V, Arnold D. Clinical significance of preoperative serum C-reactive protein in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47:16-23.
    1. Chang WC, Yang CY, Lin CS, Lin CK, Chen YW. Pretreatment body mass index as a prognostic predictor in patients with oral squamous cell carcinoma. Clin Oral Investig. 2020;24:2781-2788.
    1. Lin SC, Lin YS, Kang BH, et al. Sarcopenia results in poor survival rates in oral cavity cancer patients. Clin Otolaryngol. 2020;45:327-333.
    1. Wreesmann VB, Katabi N, Palmer FL, et al. Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1192-E1199.

Publication types

Substances

LinkOut - more resources